← All organizations
Highest phase reached
Phase 2
First clinical trial
May 31, 2019Last known activity
Sep 30, 2025
Timeline
2010s
- Apr 1, 2018
Allogene Therapeutics— Founded
Drugs by trial phase (9 distinct, 8 trials)
Phase 2 (6 own, 0 via acquisition)
Phase 1 (3 own, 0 via acquisition)
Indications
Recent trials (10)
- NCT07085104Lead sponsorPhase 1Sep 30, 2025
- NCT07085104OfficialPhase 1Sep 30, 2025
- NCT06500273Lead sponsorPhase 2Jun 18, 2024
- NCT06500273OfficialPhase 2Jun 18, 2024
- NCT05714345Lead sponsorPhase 2Mar 31, 2023
- NCT05000450Lead sponsorPhase 1/Phase 2Jun 6, 2021
- NCT04696731Lead sponsorPhase 1Feb 24, 2021
- NCT04416984Lead sponsorPhase 1/Phase 2May 21, 2020
- NCT04093596Lead sponsorPhase 1Sep 30, 2019
- NCT03939026Lead sponsorPhase 1/Phase 2May 31, 2019
Details
- Founded
- South San Francisco, CA, US Apr 1, 2018
- Last known activity
- Sep 30, 2025